Trullas R, Jackson B, Skolnick P
Laboratory of Neuroscience, NIDDK, Bethesda, MD 20892.
Pharmacol Biochem Behav. 1989 Oct;34(2):313-6. doi: 10.1016/0091-3057(89)90317-1.
The effects of 1-aminocyclopropanecarboxylic acid were investigated on performance in an elevated plus-maze. This compound is a high-affinity, partial agonist ligand at strychnine-insensitive glycine receptors of the N-methyl-D-aspartate receptor complex. Like chlordiazepoxide, 1-aminocyclopropanecarboxylic acid increased in a dose-dependent manner both the percent entries into and the percent time spent in the open arms of the plus-maze. However, 1-aminocyclopropanecarboxylic acid was significantly less efficacious than chlordiazepoxide in these measures and increased, while chlordiazepoxide decreased, the time spent in the middle platform of the plus-maze. These findings indicate that ligands acting through strychnine-insensitive glycine receptors on the N-methyl-D-aspartate receptor complex may represent a new class of anxiolytic agents with a profile which differs from the benzodiazepines.
研究了1-氨基环丙烷羧酸对高架十字迷宫实验表现的影响。该化合物是N-甲基-D-天冬氨酸受体复合物中对士的宁不敏感的甘氨酸受体的高亲和力部分激动剂配体。与氯氮卓一样,1-氨基环丙烷羧酸以剂量依赖的方式增加了进入十字迷宫开放臂的百分比和在开放臂中停留的时间百分比。然而,在这些指标上,1-氨基环丙烷羧酸的效力明显低于氯氮卓,并且它增加了在十字迷宫中间平台停留的时间,而氯氮卓则减少了这一时间。这些发现表明,通过N-甲基-D-天冬氨酸受体复合物上对士的宁不敏感的甘氨酸受体起作用的配体可能代表了一类新型的抗焦虑药物,其特性与苯二氮卓类不同。